Ads
related to: merck
Search results
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 3 hours agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 6 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
...Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside...
Fort Wayne Journal Gazette· 10 hours agoSince 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearly US$400 million
UK’s leading lab supplier launches investigation into N-word slurs on products
The Independent via Yahoo News· 3 hours agoThe products in question were created on its system in 2009 and 2023 and were provided in data files...
Dow Jones Drug Giant Merck, Nvidia Eye Buy Points In Current Stock Market
Investor's Business Daily· 2 days agoAmong the best stocks to watch, Dow Jones drug giant Merck, Nvidia, Chipotle Mexican Grill and NXP...
Here's Why Merck (MRK) is a Strong Momentum Stock
Zacks via Yahoo Finance· 5 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
Merck First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 2 days agoMerck (NYSE:MRK) First Quarter 2024 Results Key Financial Results Revenue: US$15.8b (up 8.9% from 1Q...
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha· 6 days agoPrivately held Cerevance receives milestone payment from Merck for Alzheimer's research...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 7 days agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
Gossamer sells rights to drug it hopes can rival a new Merck therapy
BioPharma Dive via Yahoo Finance· 2 days agoOne analyst thinks the collaboration “bodes well” for Gossamer, which has had trouble convincing...